Tamoxifen as Adjuvant Therapy in Breast Cancer
- 1 November 1993
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 46 (5) , 819-833
- https://doi.org/10.2165/00003495-199346050-00003
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- The case for clinical trials of tamoxifen for prevention of breast cancerThe Lancet, 1992
- Transforming growth factor β1 is implicated in the failure of tamoxifen therapy in human breast cancerBritish Journal of Cancer, 1991
- A controlled study of the ocular effects of tamoxifen in conventional dosage in the treatment of breast carcinomaEuropean Journal of Cancer and Clinical Oncology, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- The Stockholm trial on adjuvant tamoxifen in early breast cancerBreast Cancer Research and Treatment, 1987
- Effects of anti-estrogens on bone in castrated and intact female ratsBreast Cancer Research and Treatment, 1987
- DES versus Tamoxifen in Advanced Breast CancerNew England Journal of Medicine, 1981
- PROLONGED OESTROGENIC AND MITOGENIC ACTIVITY OF TAMOXIFEN IN THE OVARIECTOMIZED MOUSEJournal of Endocrinology, 1978
- INHIBITION OF OESTRADIOL BINDING TO MOUSE UTERINE AND VAGINAL OESTROGEN RECEPTORS BY TRIPHENYLETHYLENESJournal of Endocrinology, 1975
- Estrogen receptors in human breast cancerPublished by Elsevier ,1973